> top > docs > PMC:1064873 > spans > 7056-8202 > annotations

PMC:1064873 / 7056-8202 JSONTXT

Annnotations TAB JSON ListView MergeView

LappsTest

Id Subject Object Predicate Lexical cue
T6554 767-770 Protein denotes CRP
T6553 579-582 Protein denotes IgM
T6552 545-548 Protein denotes CRP
T6551 519-543 Protein denotes serum C-reactive protein

2_test

Id Subject Object Predicate Lexical cue
15535835-3358796-4156884 275-277 3358796 denotes 25
15535835-7306232-4156885 928-930 7306232 denotes 26

biosemtest

Id Subject Object Predicate Lexical cue
T6855 1019-1025 UMLS/C1519269 denotes ontrol
T6854 442-446 UMLS/C0444504 denotes ± s
T6853 87-91 UMLS/C0444504 denotes mean
T6852 442-446 UMLS/C2348143 denotes ± s
T6851 87-91 UMLS/C2348143 denotes mean
T6850 310-322 UMLS/C0032950 denotes ednisolone (
T6849 1029-1037 UMLS/C2587213 denotes T sample
T6848 775-778 UMLS/C1413716 denotes l (
T6847 551-554 UMLS/C1413716 denotes eve
T6846 1042-1049 UMLS/C2347026 denotes e obtai
T6844 775-778 UMLS/C0006560 denotes l (
T6843 551-554 UMLS/C0006560 denotes eve
T6842 531-549 UMLS/C0006560 denotes tive protein (CRP)
T6841 139-148 UMLS/C0011900 denotes agnosed a
T6840 531-549 UP/P12245 denotes tive protein (CRP)
T6839 989-992 UMLS/C0338831 denotes 45.
T6838 82-85 UMLS/C0338831 denotes men
T6837 1042-1049 UMLS/C0870078 denotes e obtai
T6835 531-549 UP/O19062 denotes tive protein (CRP)
T6834 918-926 UMLS/C1555900 denotes emission
T6833 383-391 UMLS/C1555900 denotes ical par
T6832 519-523 UMLS/C0439227 denotes seru
T6831 263-274 UMLS/C1704771 denotes sociation)
T6830 4-28 UMLS/C2361270 denotes total patient population
T6829 263-274 UMLS/C1704770 denotes sociation)
T6828 392-402 UMLS/C1704769 denotes meters in
T6827 769-774 UMLS/C1151254 denotes P lev
T6826 525-530 UMLS/C1151254 denotes C-rea
T6825 433-440 UMLS/C0332283 denotes ows (me
T6824 652-659 UMLS/C0332849 denotes into tw
T6823 433-440 UMLS/C0332282 denotes ows (me
T6822 1012-1017 UMLS/C0439234 denotes ed as
T6821 132-137 UMLS/C0439234 denotes ars)
T6820 918-926 UMLS/C1611832 denotes emission
T6819 383-391 UMLS/C1611832 denotes ical par
T6818 1029-1037 UMLS/C0332298 denotes T sample
T6817 1126-1134 UMLS/C1705908 denotes ve infor
T6816 1078-1086 UMLS/C1705908 denotes dergoing
T6815 810-818 UMLS/C1705908 denotes ith inac
T6814 680-688 UMLS/C1705908 denotes with ac
T6813 638-646 UMLS/C1705908 denotes were di
T6812 416-424 UMLS/C1705908 denotes ents wer
T6811 286-294 UMLS/C1705908 denotes tients w
T6810 45-53 UMLS/C1705908 denotes patients
T6808 669-675 UMLS/C1705429 denotes 24 pat
T6807 727-733 UMLS/C0234234 denotes nd/or
T6806 669-675 UMLS/C1705428 denotes 24 pat
T6805 760-768 UMLS/C0205250 denotes serum C
T6804 596-613 UP/P04207 denotes oid factor titer,
T6803 531-549 UP/P14847 denotes tive protein (CRP)
T6802 918-926 UMLS/C1608518 denotes emission
T6801 383-391 UMLS/C1608518 denotes ical par
T6800 531-549 UP/P49254 denotes tive protein (CRP)
T6799 775-778 UMLS/C1826658 denotes l (
T6798 551-554 UMLS/C1826658 denotes eve
T6797 149-158 UMLS/C0680240 denotes cording t
T6796 590-595 UMLS/C1547013 denotes heuma
T6795 590-595 UMLS/C1705943 denotes heuma
T6794 905-913 UMLS/C0243161 denotes or clini
T6793 179-187 UMLS/C0243161 denotes iteria o
T6792 531-549 UP/Q07203 denotes tive protein (CRP)
T6791 410-415 UMLS/C1705923 denotes y pat
T6790 252-262 UMLS/C0035435 denotes eumatism A
T6789 918-926 UMLS/C0205210 denotes emission
T6788 383-391 UMLS/C0205210 denotes ical par
T6787 869-876 UMLS/C0557806 denotes Rheuma
T6786 204-211 UMLS/C0557806 denotes llege o
T6785 880-892 UMLS/C0035452 denotes gy prelimina
T6784 215-227 UMLS/C0035452 denotes eumatology (
T6783 531-549 UP/P47875 denotes tive protein (CRP)
T6782 596-613 UMLS/C0035448 denotes oid factor titer,
T6781 669-675 UMLS/C0439745 denotes 24 pat
T6780 1029-1037 UMLS/C0243148 denotes T sample
T6779 989-992 UMLS/C1690528 denotes 45.
T6778 82-85 UMLS/C1690528 denotes men
T6777 860-868 UMLS/C0596070 denotes ollege o
T6776 243-251 UMLS/C0596070 denotes erican R
T6775 195-203 UMLS/C0596070 denotes erican C
T6774 531-549 UP/P02741 denotes tive protein (CRP)
T6773 775-778 UMLS/C1879974 denotes l (
T6772 551-554 UMLS/C1879974 denotes eve
T6771 531-549 UMLS/C1879974 denotes tive protein (CRP)
T6770 76-81 UMLS/C0205453 denotes seven
T6769 392-402 UMLS/C2350001 denotes meters in
T6768 392-402 UMLS/C0449381 denotes meters in
T6767 804-809 UMLS/C0205454 denotes ents
T6766 665-668 UMLS/C0205448 denotes ps:
T6765 769-774 UMLS/C1550100 denotes P lev
T6764 525-530 UMLS/C1550100 denotes C-rea
T6763 1069-1074 UMLS/C0205449 denotes tient
T6762 984-988 UMLS/C0205451 denotes age,
T6761 596-613 UP/P04206 denotes oid factor titer,
T6760 433-440 UMLS/C1719822 denotes ows (me
T6759 1126-1134 UMLS/C1550655 denotes ve infor
T6758 1078-1086 UMLS/C1550655 denotes dergoing
T6757 810-818 UMLS/C1550655 denotes ith inac
T6756 680-688 UMLS/C1550655 denotes with ac
T6755 638-646 UMLS/C1550655 denotes were di
T6754 416-424 UMLS/C1550655 denotes ents wer
T6753 286-294 UMLS/C1550655 denotes tients w
T6752 45-53 UMLS/C1550655 denotes patients
T6750 669-675 UMLS/C1552839 denotes 24 pat
T6749 669-675 UMLS/C1257890 denotes 24 pat
T6748 1029-1037 UMLS/C1547100 denotes T sample
T6747 519-523 UMLS/C0564385 denotes seru
T6746 300-309 UMLS/C1514756 denotes ceiving p
T6745 471-501 UMLS/C1114891 denotes rocyte sedimentation rate, 55.
T6744 531-549 UP/P02742 denotes tive protein (CRP)
T6743 718-726 UMLS/C0439064 denotes tender
T6742 1135-1139 UMLS/C1442162 denotes ed c
T6741 471-501 UMLS/C0086250 denotes rocyte sedimentation rate, 55.
T6740 694-700 UMLS/C1553875 denotes isease
T6739 727-733 UMLS/C0402364 denotes nd/or
T6738 410-415 UMLS/C0557651 denotes y pat
T6737 1042-1049 UMLS/C0441621 denotes e obtai
T6735 927-936 UMLS/C0544452 denotes [26]. Six
T6734 824-840 UMLS/C0544452 denotes isease, who sati
T6733 893-904 UMLS/C0439611 denotes y criteria
T6732 994-997 UMLS/C1114365 denotes ± 1
T6731 114-117 UMLS/C1114365 denotes ge,
T6730 344-381 UMLS/C0242708 denotes ase-modifying antirheumatic drugs. Cl
T6729 1135-1139 UMLS/C1550718 denotes ed c
T6728 779-784 UMLS/C0456079 denotes 10 m
T6727 556-561 UMLS/C0456079 denotes 32.0
T6726 1029-1037 UMLS/C1550141 denotes T sample
T6725 442-446 UMLS/C1704970 denotes ± s
T6724 87-91 UMLS/C1704970 denotes mean
T6723 769-774 UMLS/C0229671 denotes P lev
T6722 525-530 UMLS/C0229671 denotes C-rea
T6721 166-173 UMLS/C1527075 denotes vised 1
T6720 769-774 UMLS/C1546774 denotes P lev
T6719 525-530 UMLS/C1546774 denotes C-rea
T6718 880-892 UMLS/C0334889 denotes gy prelimina
T6717 215-227 UMLS/C0334889 denotes eumatology (
T6716 779-784 UMLS/C0441889 denotes 10 m
T6715 556-561 UMLS/C0441889 denotes 32.0
T6714 1012-1017 UMLS/C0439508 denotes ed as
T6713 132-137 UMLS/C0439508 denotes ars)
T6712 1098-1120 UMLS/C0086511 denotes replacement. All patie
T6711 590-595 UMLS/C0456387 denotes heuma
T6710 1055-1063 UMLS/C1706701 denotes om three
T6709 994-997 UMLS/C0001811 denotes ± 1
T6708 114-117 UMLS/C0001811 denotes ge,
T6707 994-997 UMLS/C0001779 denotes ± 1
T6706 114-117 UMLS/C0001779 denotes ge,
T6705 669-675 UMLS/C0441833 denotes 24 pat
T6704 263-274 UMLS/C0699792 denotes sociation)
T6703 410-415 UMLS/C0008972 denotes y pat
T6702 846-855 UMLS/C0242428 denotes the Ameri
T6701 410-415 UMLS/C0008976 denotes y pat
T6700 994-997 UMLS/C0001792 denotes ± 1
T6699 114-117 UMLS/C0001792 denotes ge,
T6698 1055-1063 UMLS/C1301820 denotes om three
T6697 1042-1049 UMLS/C0370003 denotes e obtai
T6695 442-446 UMLS/C0876919 denotes ± s
T6694 87-91 UMLS/C0876919 denotes mean
T6693 989-992 UMLS/C1281583 denotes 45.
T6692 82-85 UMLS/C1281583 denotes men
T6691 332-338 UMLS/C0439423 denotes ay) an
T6690 989-992 UMLS/C0086418 denotes 45.
T6689 82-85 UMLS/C0086418 denotes men
T6688 332-338 UMLS/C0439422 denotes ay) an
T6687 989-992 UMLS/C0018563 denotes 45.
T6686 82-85 UMLS/C0018563 denotes men
T6685 669-675 UMLS/C1552516 denotes 24 pat
T6684 410-415 UMLS/C2603343 denotes y pat
T6683 1029-1037 UMLS/C0009932 denotes T sample
T6682 410-415 UMLS/C2349977 denotes y pat
T6681 989-992 UMLS/C0030736 denotes 45.
T6680 82-85 UMLS/C0030736 denotes men
T6679 1126-1134 UMLS/C0030705 denotes ve infor
T6678 1078-1086 UMLS/C0030705 denotes dergoing
T6677 810-818 UMLS/C0030705 denotes ith inac
T6676 680-688 UMLS/C0030705 denotes with ac
T6675 638-646 UMLS/C0030705 denotes were di
T6674 416-424 UMLS/C0030705 denotes ents wer
T6673 286-294 UMLS/C0030705 denotes tients w
T6672 45-53 UMLS/C0030705 denotes patients
T6670 951-969 UMLS/C1708335 denotes lunteers (11 women
T6669 775-778 UMLS/C0201657 denotes l (
T6668 551-554 UMLS/C0201657 denotes eve
T6667 531-549 UMLS/C0201657 denotes tive protein (CRP)
T6666 596-613 UMLS/C0201660 denotes oid factor titer,
T6665 263-274 UMLS/C0004083 denotes sociation)
T6664 1126-1134 UMLS/C1578479 denotes ve infor
T6663 1078-1086 UMLS/C1578479 denotes dergoing
T6662 810-818 UMLS/C1578479 denotes ith inac
T6661 680-688 UMLS/C1578479 denotes with ac
T6660 638-646 UMLS/C1578479 denotes were di
T6659 416-424 UMLS/C1578479 denotes ents wer
T6658 286-294 UMLS/C1578479 denotes tients w
T6657 45-53 UMLS/C1578479 denotes patients
T6655 1126-1134 UMLS/C1578483 denotes ve infor
T6654 1078-1086 UMLS/C1578483 denotes dergoing
T6653 810-818 UMLS/C1578483 denotes ith inac
T6652 680-688 UMLS/C1578483 denotes with ac
T6651 638-646 UMLS/C1578483 denotes were di
T6650 416-424 UMLS/C1578483 denotes ents wer
T6649 286-294 UMLS/C1578483 denotes tients w
T6648 45-53 UMLS/C1578483 denotes patients
T6646 1135-1139 UMLS/C1947971 denotes ed c
T6645 1012-1017 UMLS/C1561543 denotes ed as
T6644 132-137 UMLS/C1561543 denotes ars)
T6643 1126-1134 UMLS/C1578480 denotes ve infor
T6642 1078-1086 UMLS/C1578480 denotes dergoing
T6641 810-818 UMLS/C1578480 denotes ith inac
T6640 680-688 UMLS/C1578480 denotes with ac
T6639 638-646 UMLS/C1578480 denotes were di
T6638 416-424 UMLS/C1578480 denotes ents wer
T6637 286-294 UMLS/C1578480 denotes tients w
T6636 45-53 UMLS/C1578480 denotes patients
T6634 1126-1134 UMLS/C1578481 denotes ve infor
T6633 1078-1086 UMLS/C1578481 denotes dergoing
T6632 810-818 UMLS/C1578481 denotes ith inac
T6631 680-688 UMLS/C1578481 denotes with ac
T6630 638-646 UMLS/C1578481 denotes were di
T6629 416-424 UMLS/C1578481 denotes ents wer
T6628 286-294 UMLS/C1578481 denotes tients w
T6627 45-53 UMLS/C1578481 denotes patients
T6625 1126-1134 UMLS/C1578486 denotes ve infor
T6624 1078-1086 UMLS/C1578486 denotes dergoing
T6623 810-818 UMLS/C1578486 denotes ith inac
T6622 680-688 UMLS/C1578486 denotes with ac
T6621 638-646 UMLS/C1578486 denotes were di
T6620 416-424 UMLS/C1578486 denotes ents wer
T6619 286-294 UMLS/C1578486 denotes tients w
T6618 45-53 UMLS/C1578486 denotes patients
T6616 1126-1134 UMLS/C1578484 denotes ve infor
T6615 1078-1086 UMLS/C1578484 denotes dergoing
T6614 810-818 UMLS/C1578484 denotes ith inac
T6613 680-688 UMLS/C1578484 denotes with ac
T6612 638-646 UMLS/C1578484 denotes were di
T6611 416-424 UMLS/C1578484 denotes ents wer
T6610 286-294 UMLS/C1578484 denotes tients w
T6609 45-53 UMLS/C1578484 denotes patients
T6607 1126-1134 UMLS/C1578485 denotes ve infor
T6606 1078-1086 UMLS/C1578485 denotes dergoing
T6605 810-818 UMLS/C1578485 denotes ith inac
T6604 680-688 UMLS/C1578485 denotes with ac
T6603 638-646 UMLS/C1578485 denotes were di
T6602 416-424 UMLS/C1578485 denotes ents wer
T6601 286-294 UMLS/C1578485 denotes tients w
T6600 45-53 UMLS/C1578485 denotes patients
T6598 701-708 UMLS/C0012634 denotes who ha
T6597 300-309 UMLS/C1709850 denotes ceiving p
T6596 694-700 UMLS/C1561511 denotes isease
T6595 694-700 UMLS/C1561512 denotes isease
T6594 694-700 UMLS/C1561513 denotes isease
T6593 263-274 UMLS/C0596306 denotes sociation)
T6592 989-992 UMLS/C0949399 denotes 45.
T6591 82-85 UMLS/C0949399 denotes men
T6590 984-988 UMLS/C1533153 denotes age,
T6589 263-274 UMLS/C0439849 denotes sociation)
T6588 531-549 UP/P19094 denotes tive protein (CRP)
T6587 410-415 UMLS/C1880229 denotes y pat
T6586 694-700 UMLS/C0205177 denotes isease
T6585 669-675 UMLS/C1561557 denotes 24 pat
T6584 1012-1017 UMLS/C1561544 denotes ed as
T6583 132-137 UMLS/C1561544 denotes ars)
T6582 59-65 UMLS/C0767847 denotes RA (25
T6581 741-755 UMLS/C0152031 denotes joints and ele
T6580 775-778 UMLS/C1413766 denotes l (
T6579 551-554 UMLS/C1413766 denotes eve
T6578 471-501 UMLS/C1176468 denotes rocyte sedimentation rate, 55.
T6577 694-700 UMLS/C2347179 denotes isease
T6576 159-161 UMLS/C0319022 denotes t
T6575 669-675 UMLS/C1522242 denotes 24 pat
T6574 586-589 UMLS/C0020861 denotes ss
T6573 471-501 UMLS/C1619634 denotes rocyte sedimentation rate, 55.
T6572 694-700 UMLS/C1561510 denotes isease
T6571 694-700 UMLS/C1561509 denotes isease
T6570 694-700 UMLS/C1561508 denotes isease
T6569 694-700 UMLS/C1561507 denotes isease
T6568 450-468 UMLS/C0871420 denotes ard deviation): er
T6567 95-113 UMLS/C0871420 denotes tandard deviation
T6566 392-402 UMLS/C0549193 denotes meters in
T6565 410-415 UMLS/C0947630 denotes y pat
T6564 614-619 UMLS/C0475208 denotes 142 ±
T6563 590-595 UMLS/C0489477 denotes heuma
T6562 442-446 UMLS/C2347634 denotes ± s
T6561 87-91 UMLS/C2347634 denotes mean
T6560 531-549 UP/P49262 denotes tive protein (CRP)
T6559 694-700 UMLS/C1547419 denotes isease
T6558 1029-1037 UMLS/C1882979 denotes T sample

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T7080 1138-1145 NN denotes consent
T7079 1129-1137 JJ denotes informed
T7078 1124-1128 VB denotes gave
T7077 1115-1123 NN denotes patients
T7076 1111-1114 DT denotes All
T7075 1098-1109 NN denotes replacement
T7074 1093-1097 NN denotes knee
T7073 1087-1092 JJ denotes total
T7072 1076-1086 VB denotes undergoing
T7071 1067-1075 NN denotes patients
T7070 1064-1066 NN denotes RA
T7069 1058-1063 CD denotes three
T7068 1053-1057 IN denotes from
T7067 1044-1052 VB denotes obtained
T7066 1039-1043 VB denotes were
T7065 1031-1038 NN denotes samples
T7064 1028-1030 NN denotes ST
T7063 1018-1026 NN denotes controls
T7062 1015-1017 IN denotes as
T7061 1008-1014 VB denotes served
T7060 1006-1007 -RRB- denotes )
T7059 1001-1006 NN denotes years
T7058 996-1000 CD denotes 11.2
T7057 994-995 CC denotes ±
T7056 989-993 CD denotes 45.8
T7055 987-988 -COMMA- denotes ,
T7054 984-987 NN denotes age
T7053 982-983 -COLON- denotes ;
T7052 979-982 NN denotes men
T7051 974-978 CD denotes five
T7050 970-973 CC denotes and
T7049 964-969 NN denotes women
T7048 961-963 CD denotes 11
T7047 960-961 -LRB- denotes (
T7046 949-959 NN denotes volunteers
T7045 941-948 JJ denotes healthy
T7044 933-940 CD denotes Sixteen
T7043 930-931 -RRB- denotes ]
T7042 928-930 CD denotes 26
T7041 927-928 -LRB- denotes [
T7040 917-926 NN denotes remission
T7039 908-916 JJ denotes clinical
T7038 904-907 IN denotes for
T7037 895-903 NN denotes criteria
T7036 883-894 JJ denotes preliminary
T7035 870-882 NNP denotes Rheumatology
T7034 867-869 IN denotes of
T7033 859-866 NNP denotes College
T7032 850-858 NNP denotes American
T7031 846-849 DT denotes the
T7030 836-845 VB denotes satisfied
T7029 832-835 WP denotes who
T7028 830-831 -COMMA- denotes ,
T7027 823-830 NN denotes disease
T7026 814-822 JJ denotes inactive
T7025 809-813 IN denotes with
T7024 800-808 NN denotes patients
T7023 794-799 CD denotes eight
T7022 790-793 CC denotes and
T7021 788-789 -COLON- denotes ;
T7020 787-788 -RRB- denotes )
T7019 783-787 NN denotes mg/l
T7018 780-782 CD denotes 10
T7017 778-779 NN denotes
T6952 438-442 JJ denotes mean
T6951 437-438 -LRB- denotes (
T6950 429-436 VB denotes follows
T6949 426-428 RB denotes as
T6948 421-425 VB denotes were
T6947 412-420 NN denotes patients
T6946 406-411 NN denotes study
T6945 402-405 DT denotes the
T6944 399-401 IN denotes in
T6943 388-398 NN denotes parameters
T6942 379-387 JJ denotes Clinical
T6941 372-377 NN denotes drugs
T6940 358-371 JJ denotes antirheumatic
T6939 340-357 JJ denotes disease-modifying
T6938 336-339 CC denotes and
T6937 334-335 -RRB- denotes )
T6936 328-334 NN denotes mg/day
T6935 324-327 CD denotes 7.5
T6934 322-323 SYM denotes
T6933 321-322 -LRB- denotes (
T6932 308-320 NN denotes prednisolone
T6931 298-307 VB denotes receiving
T6930 293-297 VB denotes were
T6929 284-292 NN denotes patients
T6928 280-283 DT denotes All
T6927 277-278 -RRB- denotes ]
T6926 275-277 CD denotes 25
T6925 274-275 -LRB- denotes [
T6924 272-273 -RRB- denotes )
T6923 261-272 NNP denotes Association
T6922 250-260 NNP denotes Rheumatism
T6921 241-249 NNP denotes American
T6920 237-240 DT denotes the
T6919 235-236 -COMMA- denotes ,
T6918 227-235 RB denotes formally
T6917 226-227 -LRB- denotes (
T6916 213-225 NNP denotes Rheumatology
T6915 210-212 IN denotes of
T6914 202-209 NNP denotes College
T6913 193-201 NNP denotes American
T6912 189-192 DT denotes the
T6911 186-188 IN denotes of
T6910 177-185 NN denotes criteria
T6909 172-176 CD denotes 1987
T6908 164-171 VB denotes revised
T6907 160-163 DT denotes the
T6906 157-159 TO denotes to
T6905 147-156 VB denotes according
T6904 137-146 VB denotes diagnosed
T6903 135-136 -RRB- denotes )
T6902 130-135 NN denotes years
T6901 125-129 CD denotes 12.4
T6900 123-124 CC denotes ±
T6899 118-122 CD denotes 52.8
T6898 116-117 -COMMA- denotes ,
T6897 113-116 NN denotes age
T6896 103-112 NN denotes deviation
T6895 94-102 JJ denotes standard
T6894 92-93 JJ denotes ±
T6893 87-91 JJ denotes mean
T6892 85-86 -COLON- denotes ;
T6891 82-85 NN denotes men
T6890 76-81 CD denotes seven
T6889 72-75 CC denotes and
T6888 66-71 NN denotes women
T6887 63-65 CD denotes 25
T6886 62-63 -LRB- denotes (
T6885 59-61 NN denotes RA
T6884 54-58 IN denotes with
T6883 45-53 NN denotes patients
T6882 42-44 CD denotes 32
T6881 39-41 IN denotes of
T6880 29-38 VB denotes consisted
T6879 18-28 NN denotes population
T6878 10-17 NN denotes patient
T6877 4-9 JJ denotes total
T6876 0-3 DT denotes The
T7016 777-778 -LRB- denotes (
T7015 771-776 NN denotes level
T7014 767-770 NN denotes CRP
T7013 761-766 NN denotes serum
T7012 752-760 VB denotes elevated
T7011 748-751 CC denotes and
T7010 741-747 NN denotes joints
T7009 733-740 VB denotes swollen
T7008 726-732 CC denotes and/or
T7007 719-725 NN denotes tender
T7006 710-718 JJ denotes multiple
T7005 706-709 VB denotes had
T7004 702-705 WP denotes who
T7003 700-701 -COMMA- denotes ,
T7002 693-700 NN denotes disease
T7001 686-692 JJ denotes active
T7000 681-685 IN denotes with
T6999 672-680 NN denotes patients
T6998 669-671 CD denotes 24
T6997 667-668 -COLON- denotes :
T6996 661-667 NN denotes groups
T6995 657-660 CD denotes two
T6994 652-656 IN denotes into
T6993 644-651 VB denotes divided
T6992 639-643 VB denotes were
T6991 630-638 NN denotes Patients
T6990 624-628 NN denotes U/ml
T6989 620-623 CD denotes 158
T6988 618-619 -COLON- denotes ±
T6987 614-617 CD denotes 142
T6986 612-613 -COMMA- denotes ,
T6985 607-612 NN denotes titer
T6984 600-606 NN denotes factor
T6983 589-599 JJ denotes rheumatoid
T6982 583-588 NN denotes class
T6981 579-582 NN denotes IgM
T6980 575-578 CC denotes and
T6979 573-574 -COLON- denotes ;
T6978 569-573 NN denotes mg/l
T6977 564-568 CD denotes 32.0
T6976 562-563 -COLON- denotes ±
T6975 557-561 CD denotes 32.0
T6974 555-556 -COMMA- denotes ,
T6973 550-555 NN denotes level
T6972 548-549 -RRB- denotes )
T6971 545-548 NN denotes CRP
T6970 544-545 -LRB- denotes (
T6969 536-543 NN denotes protein
T6968 525-535 JJ denotes C-reactive
T6967 519-524 NN denotes serum
T6966 517-518 -COLON- denotes ;
T6965 510-517 NN denotes mm/hour
T6964 505-509 CD denotes 35.4
T6963 503-504 -COLON- denotes ±
T6962 498-502 CD denotes 55.9
T6961 496-497 -COMMA- denotes ,
T6960 492-496 NN denotes rate
T6959 478-491 NN denotes sedimentation
T6958 466-477 NN denotes erythrocyte
T6957 464-465 -COLON- denotes :
T6956 463-464 -RRB- denotes )
T6955 454-463 NN denotes deviation
T6954 445-453 JJ denotes standard
T6953 443-444 JJ denotes ±
R3195 T6879 T6876 arg1Of population,The
R3196 T6879 T6877 arg1Of population,total
R3197 T6879 T6878 arg1Of population,patient
R3198 T6879 T6880 arg1Of population,consisted
R3199 T6880 T6881 arg1Of consisted,of
R3200 T6880 T6925 arg1Of consisted,[
R3201 T6883 T6881 arg2Of patients,of
R3202 T6883 T6882 arg1Of patients,32
R3203 T6883 T6884 arg1Of patients,with
R3204 T6883 T6886 arg1Of patients,(
R3205 T6883 T6904 arg2Of patients,diagnosed
R3206 T6883 T6915 arg1Of patients,of
R3207 T6885 T6884 arg2Of RA,with
R3208 T6888 T6887 arg1Of women,25
R3209 T6888 T6889 arg1Of women,and
R3210 T6889 T6886 arg2Of and,(
R3211 T6889 T6892 arg1Of and,;
R3212 T6891 T6889 arg2Of men,and
R3213 T6891 T6890 arg1Of men,seven
R3214 T6897 T6892 arg2Of age,;
R3215 T6897 T6893 arg1Of age,mean
R3216 T6897 T6894 arg1Of age,±
R3217 T6897 T6895 arg1Of age,standard
R3218 T6897 T6896 arg1Of age,deviation
R3219 T6897 T6898 arg1Of age,","
R3220 T6899 T6900 arg1Of 52.8,±
R3221 T6901 T6900 arg2Of 12.4,±
R3222 T6902 T6898 arg2Of years,","
R3223 T6902 T6899 arg1Of years,52.8
R3224 T6902 T6901 arg1Of years,12.4
R3225 T6903 T6886 arg3Of ),(
R3226 T6904 T6905 arg1Of diagnosed,according
R3227 T6906 T6905 arg2Of to,according
R3228 T6910 T6906 arg2Of criteria,to
R3229 T6910 T6907 arg1Of criteria,the
R3230 T6910 T6908 arg2Of criteria,revised
R3231 T6910 T6909 arg1Of criteria,1987
R3232 T6910 T6911 arg1Of criteria,of
R3233 T6914 T6911 arg2Of College,of
R3234 T6914 T6912 arg1Of College,the
R3235 T6914 T6913 arg1Of College,American
R3236 T6916 T6915 arg2Of Rheumatology,of
R3237 T6916 T6917 arg1Of Rheumatology,(
R3238 T6923 T6917 arg2Of Association,(
R3239 T6923 T6918 arg1Of Association,formally
R3240 T6923 T6919 arg1Of Association,","
R3241 T6923 T6920 arg1Of Association,the
R3242 T6923 T6921 arg1Of Association,American
R3243 T6923 T6922 arg1Of Association,Rheumatism
R3244 T6924 T6917 arg3Of ),(
R3245 T6926 T6925 arg2Of 25,[
R3246 T6927 T6925 arg3Of ],[
R3247 T6929 T6928 arg1Of patients,All
R3248 T6929 T6930 arg1Of patients,were
R3249 T6929 T6931 arg1Of patients,receiving
R3250 T6931 T6930 arg2Of receiving,were
R3251 T6932 T6933 arg1Of prednisolone,(
R3252 T6932 T6938 arg1Of prednisolone,and
R3253 T6935 T6934 arg1Of 7.5,≤
R3254 T6936 T6933 arg2Of mg/day,(
R3255 T6936 T6935 arg1Of mg/day,7.5
R3256 T6937 T6933 arg3Of ),(
R3257 T6938 T6931 arg2Of and,receiving
R3258 T6941 T6938 arg2Of drugs,and
R3259 T6941 T6939 arg1Of drugs,disease-modifying
R3260 T6941 T6940 arg1Of drugs,antirheumatic
R3261 T6943 T6942 arg1Of parameters,Clinical
R3262 T6943 T6944 arg1Of parameters,in
R3263 T6943 T6950 arg1Of parameters,follows
R3264 T6946 T6944 arg2Of study,in
R3265 T6946 T6945 arg1Of study,the
R3266 T6946 T6948 arg2Of study,were
R3267 T6947 T6948 arg1Of patients,were
R3268 T6950 T6949 arg1Of follows,as
R3269 T6950 T6951 arg1Of follows,(
R3270 T6950 T6957 arg1Of follows,:
R3271 T6950 T6965 arg1Of follows,mm/hour
R3272 T6950 T6990 arg1Of follows,U/ml
R3273 T6955 T6951 arg2Of deviation,(
R3274 T6955 T6952 arg1Of deviation,mean
R3275 T6955 T6953 arg1Of deviation,±
R3276 T6955 T6954 arg1Of deviation,standard
R3277 T6956 T6951 arg3Of ),(
R3278 T6960 T6950 arg2Of rate,follows
R3279 T6960 T6958 arg1Of rate,erythrocyte
R3280 T6960 T6959 arg1Of rate,sedimentation
R3281 T6960 T6961 arg1Of rate,","
R3282 T6962 T6961 arg2Of 55.9,","
R3283 T6965 T6963 arg1Of mm/hour,±
R3284 T6965 T6964 arg1Of mm/hour,35.4
R3285 T6965 T6966 arg1Of mm/hour,;
R3286 T6971 T6970 arg2Of CRP,(
R3287 T6972 T6970 arg3Of ),(
R3288 T6973 T6966 arg2Of level,;
R3289 T6973 T6967 arg1Of level,serum
R3290 T6973 T6968 arg1Of level,C-reactive
R3291 T6973 T6969 arg1Of level,protein
R3292 T6973 T6970 arg1Of level,(
R3293 T6973 T6974 arg1Of level,","
R3294 T6973 T6986 arg1Of level,","
R3295 T6975 T6978 arg1Of 32.0,mg/l
R3296 T6975 T6982 arg1Of 32.0,class
R3297 T6978 T6977 arg1Of mg/l,32.0
R3298 T6978 T6980 arg1Of mg/l,and
R3299 T6980 T6976 arg1Of and,±
R3300 T6980 T6979 arg1Of and,;
R3301 T6982 T6980 arg2Of class,and
R3302 T6982 T6981 arg1Of class,IgM
R3303 T6985 T6974 arg2Of titer,","
R3304 T6985 T6975 arg1Of titer,32.0
R3305 T6985 T6983 arg1Of titer,rheumatoid
R3306 T6985 T6984 arg1Of titer,factor
R3307 T6987 T6986 arg2Of 142,","
R3308 T6990 T6988 arg1Of U/ml,±
R3309 T6990 T6989 arg1Of U/ml,158
R3310 T6991 T6992 arg1Of Patients,were
R3311 T6991 T6993 arg2Of Patients,divided
R3312 T6993 T6992 arg2Of divided,were
R3313 T6993 T6994 arg1Of divided,into
R3314 T6993 T6997 arg1Of divided,:
R3315 T6996 T6994 arg2Of groups,into
R3316 T6996 T6995 arg1Of groups,two
R3317 T6999 T6998 arg1Of patients,24
R3318 T6999 T7000 arg1Of patients,with
R3319 T6999 T7003 arg1Of patients,","
R3320 T6999 T7004 arg1Of patients,who
R3321 T6999 T7005 arg1Of patients,had
R3322 T7002 T7000 arg2Of disease,with
R3323 T7002 T7001 arg1Of disease,active
R3324 T7007 T7006 arg1Of tender,multiple
R3325 T7007 T7008 arg1Of tender,and/or
R3326 T7008 T7011 arg1Of and/or,and
R3327 T7010 T7008 arg2Of joints,and/or
R3328 T7010 T7009 arg2Of joints,swollen
R3329 T7011 T7022 arg1Of and,and
R3330 T7015 T7011 arg2Of level,and
R3331 T7015 T7012 arg2Of level,elevated
R3332 T7015 T7013 arg1Of level,serum
R3333 T7015 T7014 arg1Of level,CRP
R3334 T7015 T7016 arg1Of level,(
R3335 T7019 T7016 arg2Of mg/l,(
R3336 T7019 T7017 arg1Of mg/l,≥
R3337 T7019 T7018 arg1Of mg/l,10
R3338 T7020 T7016 arg3Of ),(
R3339 T7022 T7005 arg2Of and,had
R3340 T7022 T7021 arg1Of and,;
R3341 T7022 T7029 arg1Of and,who
R3342 T7022 T7030 arg1Of and,satisfied
R3343 T7024 T7022 arg2Of patients,and
R3344 T7024 T7023 arg1Of patients,eight
R3345 T7024 T7025 arg1Of patients,with
R3346 T7024 T7028 arg1Of patients,","
R3347 T7027 T7025 arg2Of disease,with
R3348 T7027 T7026 arg1Of disease,inactive
R3349 T7033 T7032 arg1Of College,American
R3350 T7033 T7034 arg1Of College,of
R3351 T7035 T7034 arg2Of Rheumatology,of
R3352 T7037 T7030 arg2Of criteria,satisfied
R3353 T7037 T7031 arg1Of criteria,the
R3354 T7037 T7033 arg1Of criteria,College
R3355 T7037 T7036 arg1Of criteria,preliminary
R3356 T7037 T7038 arg1Of criteria,for
R3357 T7040 T7038 arg2Of remission,for
R3358 T7040 T7039 arg1Of remission,clinical
R3359 T7040 T7041 arg1Of remission,[
R3360 T7042 T7041 arg2Of 26,[
R3361 T7043 T7041 arg3Of ],[
R3362 T7046 T7044 arg1Of volunteers,Sixteen
R3363 T7046 T7045 arg1Of volunteers,healthy
R3364 T7046 T7047 arg1Of volunteers,(
R3365 T7046 T7061 arg1Of volunteers,served
R3366 T7049 T7048 arg1Of women,11
R3367 T7049 T7050 arg1Of women,and
R3368 T7050 T7047 arg2Of and,(
R3369 T7050 T7053 arg1Of and,;
R3370 T7052 T7050 arg2Of men,and
R3371 T7052 T7051 arg1Of men,five
R3372 T7054 T7053 arg2Of age,;
R3373 T7054 T7055 arg1Of age,","
R3374 T7056 T7057 arg1Of 45.8,±
R3375 T7058 T7057 arg2Of 11.2,±
R3376 T7059 T7055 arg2Of years,","
R3377 T7059 T7056 arg1Of years,45.8
R3378 T7059 T7058 arg1Of years,11.2
R3379 T7060 T7047 arg3Of ),(
R3380 T7061 T7062 arg1Of served,as
R3381 T7063 T7062 arg2Of controls,as
R3382 T7065 T7064 arg1Of samples,ST
R3383 T7065 T7066 arg1Of samples,were
R3384 T7065 T7067 arg2Of samples,obtained
R3385 T7067 T7066 arg2Of obtained,were
R3386 T7067 T7068 arg1Of obtained,from
R3387 T7071 T7068 arg2Of patients,from
R3388 T7071 T7069 arg1Of patients,three
R3389 T7071 T7070 arg1Of patients,RA
R3390 T7071 T7072 arg1Of patients,undergoing
R3391 T7075 T7072 arg2Of replacement,undergoing
R3392 T7075 T7073 arg1Of replacement,total
R3393 T7075 T7074 arg1Of replacement,knee
R3394 T7077 T7076 arg1Of patients,All
R3395 T7077 T7078 arg1Of patients,gave
R3396 T7080 T7078 arg2Of consent,gave
R3397 T7080 T7079 arg1Of consent,informed

UBERON-AE

Id Subject Object Predicate Lexical cue
T6557 1093-1097 http://purl.obolibrary.org/obo/UBERON_0001465 denotes knee
T6556 761-766 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T6555 519-524 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

GO-BP

Id Subject Object Predicate Lexical cue
T6866 984-987 http://purl.obolibrary.org/obo/GO_0007568 denotes age
T6865 113-116 http://purl.obolibrary.org/obo/GO_0007568 denotes age

sentences

Id Subject Object Predicate Lexical cue
T6864 1111-1146 Sentence denotes All patients gave informed consent.
T6863 1028-1110 Sentence denotes ST samples were obtained from three RA patients undergoing total knee replacement.
T6862 933-1027 Sentence denotes Sixteen healthy volunteers (11 women and five men; age, 45.8 ± 11.2 years) served as controls.
T6861 669-932 Sentence denotes 24 patients with active disease, who had multiple tender and/or swollen joints and elevated serum CRP level (≥ 10 mg/l); and eight patients with inactive disease, who satisfied the American College of Rheumatology preliminary criteria for clinical remission [26].
T6860 630-668 Sentence denotes Patients were divided into two groups:
T6859 379-629 Sentence denotes Clinical parameters in the study patients were as follows (mean ± standard deviation): erythrocyte sedimentation rate, 55.9 ± 35.4 mm/hour; serum C-reactive protein (CRP) level, 32.0 ± 32.0 mg/l; and IgM class rheumatoid factor titer, 142 ± 158 U/ml.
T6858 280-378 Sentence denotes All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs.
T6857 0-279 Sentence denotes The total patient population consisted of 32 patients with RA (25 women and seven men; mean ± standard deviation age, 52.8 ± 12.4 years) diagnosed according to the revised 1987 criteria of the American College of Rheumatology (formally, the American Rheumatism Association) [25].
T38 0-279 Sentence denotes The total patient population consisted of 32 patients with RA (25 women and seven men; mean ± standard deviation age, 52.8 ± 12.4 years) diagnosed according to the revised 1987 criteria of the American College of Rheumatology (formally, the American Rheumatism Association) [25].
T39 280-378 Sentence denotes All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs.
T40 379-629 Sentence denotes Clinical parameters in the study patients were as follows (mean ± standard deviation): erythrocyte sedimentation rate, 55.9 ± 35.4 mm/hour; serum C-reactive protein (CRP) level, 32.0 ± 32.0 mg/l; and IgM class rheumatoid factor titer, 142 ± 158 U/ml.
T41 630-668 Sentence denotes Patients were divided into two groups:
T42 669-932 Sentence denotes 24 patients with active disease, who had multiple tender and/or swollen joints and elevated serum CRP level (≥ 10 mg/l); and eight patients with inactive disease, who satisfied the American College of Rheumatology preliminary criteria for clinical remission [26].
T43 933-1027 Sentence denotes Sixteen healthy volunteers (11 women and five men; age, 45.8 ± 11.2 years) served as controls.
T44 1028-1110 Sentence denotes ST samples were obtained from three RA patients undergoing total knee replacement.
T45 1111-1146 Sentence denotes All patients gave informed consent.

ICD10

Id Subject Object Predicate Lexical cue
T6867 250-260 http://purl.bioontology.org/ontology/ICD10/M79.0 denotes Rheumatism

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T7311 767-770 Protein denotes CRP
T7310 340-377 Entity denotes disease-modifying antirheumatic drugs
T7309 59-61 Protein denotes RA
T7308 545-548 Protein denotes CRP
T7307 308-335 Entity denotes prednisolone (≤ 7.5 mg/day)
T7306 589-606 Protein denotes rheumatoid factor
T7305 525-549 Protein denotes C-reactive protein (CRP)
T7304 466-477 Entity denotes erythrocyte
T7303 614-625 Entity denotes 142 ± 158 U
T7302 1028-1030 Protein denotes ST
T7301 1064-1066 Protein denotes RA

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T7232 788-789 : denotes ;
T7231 787-788 -RRB- denotes )
T7230 783-787 NN denotes mg/l
T7229 780-782 CD denotes 10
T7228 778-779 FW denotes
T7227 777-778 -LRB- denotes (
T7226 771-776 NN denotes level
T7225 767-770 NNP denotes CRP
T7224 761-766 NN denotes serum
T7223 752-760 JJ denotes elevated
T7222 748-751 CC denotes and
T7221 741-747 NNS denotes joints
T7220 733-740 JJ denotes swollen
T7219 726-732 CC denotes and/or
T7218 719-725 NN denotes tender
T7217 710-718 JJ denotes multiple
T7216 706-709 VBD denotes had
T7215 702-705 WP denotes who
T7214 700-701 , denotes ,
T7213 693-700 NN denotes disease
T7212 686-692 JJ denotes active
T7211 681-685 IN denotes with
T7210 672-680 NNS denotes patients
T7209 669-671 CD denotes 24
T7208 667-668 : denotes :
T7207 661-667 NNS denotes groups
T7206 657-660 CD denotes two
T7205 652-656 IN denotes into
T7204 644-651 VBN denotes divided
T7203 639-643 VBD denotes were
T7202 630-638 NNS denotes Patients
T7201 628-629 . denotes .
T7200 624-628 NNP denotes U/ml
T7199 620-623 CD denotes 158
T7198 618-619 NN denotes ±
T7197 614-617 CD denotes 142
T7196 612-613 , denotes ,
T7195 607-612 NN denotes titer
T7194 600-606 NN denotes factor
T7193 589-599 JJ denotes rheumatoid
T7192 583-588 NN denotes class
T7191 579-582 NNP denotes IgM
T7190 575-578 CC denotes and
T7189 573-574 : denotes ;
T7188 569-573 NN denotes mg/l
T7187 564-568 CD denotes 32.0
T7186 562-563 CD denotes ±
T7185 557-561 CD denotes 32.0
T7184 555-556 , denotes ,
T7183 550-555 NN denotes level
T7182 548-549 -RRB- denotes )
T7181 545-548 NNP denotes CRP
T7180 544-545 -LRB- denotes (
T7179 536-543 NN denotes protein
T7178 525-535 JJ denotes C-reactive
T7177 519-524 NN denotes serum
T7176 517-518 : denotes ;
T7175 510-517 NN denotes mm/hour
T7174 505-509 CD denotes 35.4
T7173 503-504 CD denotes ±
T7172 498-502 CD denotes 55.9
T7171 496-497 , denotes ,
T7170 492-496 NN denotes rate
T7169 478-491 NN denotes sedimentation
T7168 466-477 VB denotes erythrocyte
T7167 464-465 : denotes :
T7166 463-464 -RRB- denotes )
T7165 454-463 NN denotes deviation
T7164 445-453 JJ denotes standard
T7163 443-444 JJ denotes ±
T7162 438-442 VB denotes mean
T7161 437-438 -LRB- denotes (
T7160 429-436 VBZ denotes follows
T7159 426-428 IN denotes as
T7158 421-425 VBD denotes were
T7157 412-420 NNS denotes patients
T7156 406-411 NN denotes study
T7155 402-405 DT denotes the
T7154 399-401 IN denotes in
T7153 388-398 NNS denotes parameters
T7152 379-387 JJ denotes Clinical
T7151 377-378 . denotes .
T7150 372-377 NNS denotes drugs
T7149 358-371 JJ denotes antirheumatic
T7148 340-357 JJ denotes disease-modifying
T7147 336-339 CC denotes and
T7146 334-335 -RRB- denotes )
T7145 328-334 NN denotes mg/day
T7144 324-327 CD denotes 7.5
T7143 322-323 CD denotes
T7142 321-322 -LRB- denotes (
T7141 308-320 NN denotes prednisolone
T7140 298-307 VBG denotes receiving
T7139 293-297 VBD denotes were
T7138 284-292 NNS denotes patients
T7137 280-283 DT denotes All
T7136 278-279 . denotes .
T7135 277-278 NNP denotes ]
T7134 275-277 CD denotes 25
T7133 274-275 NNP denotes [
T7132 272-273 -RRB- denotes )
T7131 261-272 NNP denotes Association
T7130 250-260 NNP denotes Rheumatism
T7129 241-249 JJ denotes American
T7128 237-240 DT denotes the
T7127 235-236 , denotes ,
T7126 227-235 RB denotes formally
T7125 226-227 -LRB- denotes (
T7124 213-225 NNP denotes Rheumatology
T7123 210-212 IN denotes of
T7122 202-209 NNP denotes College
T7121 193-201 JJ denotes American
T7120 189-192 DT denotes the
T7119 186-188 IN denotes of
T7118 177-185 NNS denotes criteria
T7117 172-176 CD denotes 1987
T7116 164-171 VBN denotes revised
T7115 160-163 DT denotes the
T7114 157-159 TO denotes to
T7113 147-156 VBG denotes according
T7112 137-146 VBN denotes diagnosed
T7111 135-136 -RRB- denotes )
T7110 130-135 NNS denotes years
T7109 125-129 CD denotes 12.4
T7108 123-124 NN denotes ±
T7107 118-122 CD denotes 52.8
T7106 116-117 , denotes ,
T7105 113-116 NN denotes age
T7104 103-112 NN denotes deviation
T7103 94-102 JJ denotes standard
T7102 92-93 JJ denotes ±
T7101 87-91 VB denotes mean
T7100 85-86 : denotes ;
T7099 82-85 NNS denotes men
T7098 76-81 CD denotes seven
T7097 72-75 CC denotes and
T7096 66-71 NNS denotes women
T7095 63-65 CD denotes 25
T7094 62-63 -LRB- denotes (
T7093 59-61 NNP denotes RA
T7092 54-58 IN denotes with
T7091 45-53 NNS denotes patients
T7090 42-44 CD denotes 32
T7089 39-41 IN denotes of
T7088 29-38 VBD denotes consisted
T7087 18-28 NN denotes population
T7086 10-17 JJ denotes patient
T7085 4-9 JJ denotes total
T7084 0-3 DT denotes The
T7295 1145-1146 . denotes .
T7294 1138-1145 NN denotes consent
T7293 1129-1137 VBN denotes informed
T7292 1124-1128 VBD denotes gave
T7291 1115-1123 NNS denotes patients
T7290 1111-1114 DT denotes All
T7289 1109-1110 . denotes .
T7288 1098-1109 NN denotes replacement
T7287 1093-1097 NN denotes knee
T7286 1087-1092 JJ denotes total
T7285 1076-1086 VBG denotes undergoing
T7265 982-983 : denotes ;
T7264 979-982 NNS denotes men
T7263 974-978 CD denotes five
T7262 970-973 CC denotes and
T7261 964-969 NNS denotes women
T7260 961-963 CD denotes 11
T7259 960-961 -LRB- denotes (
T7258 949-959 NNS denotes volunteers
T7257 941-948 JJ denotes healthy
T7256 933-940 CD denotes Sixteen
T7255 931-932 . denotes .
T7254 930-931 NNP denotes ]
T7253 928-930 CD denotes 26
T7252 927-928 NNP denotes [
T7251 917-926 NN denotes remission
T7250 908-916 JJ denotes clinical
T7249 904-907 IN denotes for
T7248 895-903 NNS denotes criteria
T7247 883-894 JJ denotes preliminary
T7246 870-882 NNP denotes Rheumatology
T7245 867-869 IN denotes of
T7244 859-866 NNP denotes College
T7243 850-858 JJ denotes American
T7242 846-849 DT denotes the
T7241 836-845 VBD denotes satisfied
T7240 832-835 WP denotes who
T7239 830-831 , denotes ,
T7238 823-830 NN denotes disease
T7237 814-822 JJ denotes inactive
T7236 809-813 IN denotes with
T7235 800-808 NNS denotes patients
T7234 794-799 CD denotes eight
T7233 790-793 CC denotes and
T7284 1067-1075 NNS denotes patients
T7283 1064-1066 NNP denotes RA
T7282 1058-1063 CD denotes three
T7281 1053-1057 IN denotes from
T7280 1044-1052 VBN denotes obtained
T7279 1039-1043 VBD denotes were
T7278 1031-1038 NNS denotes samples
T7277 1028-1030 NNP denotes ST
T7276 1026-1027 . denotes .
T7275 1018-1026 NNS denotes controls
T7274 1015-1017 IN denotes as
T7273 1008-1014 VBD denotes served
T7272 1006-1007 -RRB- denotes )
T7271 1001-1006 NNS denotes years
T7270 996-1000 CD denotes 11.2
T7269 994-995 NN denotes ±
T7268 989-993 CD denotes 45.8
T7267 987-988 , denotes ,
T7266 984-987 NN denotes age
R3401 T7084 T7087 det The,population
R3402 T7085 T7087 amod total,population
R3403 T7086 T7087 amod patient,population
R3404 T7087 T7088 nsubj population,consisted
R3405 T7088 T7101 ccomp consisted,mean
R3406 T7089 T7088 prep of,consisted
R3407 T7090 T7091 nummod 32,patients
R3408 T7091 T7089 pobj patients,of
R3409 T7092 T7091 prep with,patients
R3410 T7093 T7092 pobj RA,with
R3411 T7094 T7093 punct (,RA
R3412 T7095 T7096 nummod 25,women
R3413 T7096 T7093 appos women,RA
R3414 T7097 T7096 cc and,women
R3415 T7098 T7099 nummod seven,men
R3416 T7099 T7096 conj men,women
R3417 T7100 T7101 punct ;,mean
R3418 T7101 T7101 ROOT mean,mean
R3419 T7102 T7105 amod ±,age
R3420 T7103 T7104 amod standard,deviation
R3421 T7104 T7105 compound deviation,age
R3422 T7105 T7101 dobj age,mean
R3423 T7106 T7105 punct ",",age
R3424 T7107 T7108 nummod 52.8,±
R3425 T7108 T7105 appos ±,age
R3426 T7109 T7110 nummod 12.4,years
R3427 T7110 T7108 appos years,±
R3428 T7111 T7105 punct ),age
R3429 T7112 T7105 acl diagnosed,age
R3430 T7113 T7112 prep according,diagnosed
R3431 T7114 T7113 prep to,according
R3432 T7115 T7118 det the,criteria
R3433 T7116 T7118 amod revised,criteria
R3434 T7117 T7118 nummod 1987,criteria
R3435 T7118 T7114 pobj criteria,to
R3436 T7119 T7118 prep of,criteria
R3437 T7120 T7122 det the,College
R3438 T7121 T7122 compound American,College
R3439 T7122 T7119 pobj College,of
R3440 T7123 T7122 prep of,College
R3441 T7124 T7123 pobj Rheumatology,of
R3442 T7125 T7131 punct (,Association
R3443 T7126 T7131 advmod formally,Association
R3444 T7127 T7131 punct ",",Association
R3445 T7128 T7131 det the,Association
R3446 T7129 T7131 compound American,Association
R3447 T7130 T7131 compound Rheumatism,Association
R3448 T7131 T7122 appos Association,College
R3449 T7132 T7133 punct ),[
R3450 T7133 T7135 nmod [,]
R3451 T7134 T7135 nummod 25,]
R3452 T7135 T7131 appos ],Association
R3453 T7136 T7101 punct .,mean
R3454 T7137 T7138 det All,patients
R3455 T7138 T7140 nsubj patients,receiving
R3456 T7139 T7140 aux were,receiving
R3457 T7140 T7140 ROOT receiving,receiving
R3458 T7141 T7140 dobj prednisolone,receiving
R3459 T7142 T7141 punct (,prednisolone
R3460 T7143 T7141 appos ≤,prednisolone
R3461 T7144 T7145 nummod 7.5,mg/day
R3462 T7145 T7143 appos mg/day,≤
R3463 T7146 T7145 punct ),mg/day
R3464 T7147 T7145 cc and,mg/day
R3465 T7148 T7150 amod disease-modifying,drugs
R3466 T7149 T7150 amod antirheumatic,drugs
R3467 T7150 T7145 conj drugs,mg/day
R3468 T7151 T7140 punct .,receiving
R3469 T7152 T7153 amod Clinical,parameters
R3470 T7153 T7158 nsubj parameters,were
R3471 T7154 T7153 prep in,parameters
R3472 T7155 T7157 det the,patients
R3473 T7156 T7157 compound study,patients
R3474 T7157 T7154 pobj patients,in
R3475 T7158 T7158 ROOT were,were
R3476 T7159 T7160 mark as,follows
R3477 T7160 T7158 advcl follows,were
R3478 T7161 T7162 punct (,mean
R3479 T7162 T7170 meta mean,rate
R3480 T7163 T7165 nmod ±,deviation
R3481 T7164 T7165 amod standard,deviation
R3482 T7165 T7162 dobj deviation,mean
R3483 T7166 T7162 punct ),mean
R3484 T7167 T7162 punct :,mean
R3485 T7168 T7170 compound erythrocyte,rate
R3486 T7169 T7170 compound sedimentation,rate
R3487 T7170 T7160 nsubj rate,follows
R3488 T7171 T7170 punct ",",rate
R3489 T7172 T7175 nummod 55.9,mm/hour
R3490 T7173 T7175 nmod ±,mm/hour
R3491 T7174 T7175 nummod 35.4,mm/hour
R3492 T7175 T7170 appos mm/hour,rate
R3493 T7176 T7170 punct ;,rate
R3494 T7177 T7179 nmod serum,protein
R3495 T7178 T7179 amod C-reactive,protein
R3496 T7179 T7170 appos protein,rate
R3497 T7180 T7181 punct (,CRP
R3498 T7181 T7179 appos CRP,protein
R3499 T7182 T7181 punct ),CRP
R3500 T7183 T7179 appos level,protein
R3501 T7184 T7179 punct ",",protein
R3502 T7185 T7188 nummod 32.0,mg/l
R3503 T7186 T7188 nummod ±,mg/l
R3504 T7187 T7188 nummod 32.0,mg/l
R3505 T7188 T7179 appos mg/l,protein
R3506 T7189 T7170 punct ;,rate
R3507 T7190 T7170 cc and,rate
R3508 T7191 T7192 compound IgM,class
R3509 T7192 T7194 compound class,factor
R3510 T7193 T7194 compound rheumatoid,factor
R3511 T7194 T7195 compound factor,titer
R3512 T7195 T7170 conj titer,rate
R3513 T7196 T7195 punct ",",titer
R3514 T7197 T7199 quantmod 142,158
R3515 T7198 T7199 quantmod ±,158
R3516 T7199 T7200 nummod 158,U/ml
R3517 T7200 T7170 conj U/ml,rate
R3518 T7201 T7158 punct .,were
R3519 T7202 T7204 nsubjpass Patients,divided
R3520 T7203 T7204 auxpass were,divided
R3521 T7204 T7204 ROOT divided,divided
R3522 T7205 T7204 prep into,divided
R3523 T7206 T7207 nummod two,groups
R3524 T7207 T7205 pobj groups,into
R3525 T7208 T7207 punct :,groups
R3526 T7209 T7210 nummod 24,patients
R3527 T7210 T7207 appos patients,groups
R3528 T7211 T7210 prep with,patients
R3529 T7212 T7213 amod active,disease
R3530 T7213 T7211 pobj disease,with
R3531 T7214 T7213 punct ",",disease
R3532 T7215 T7216 nsubj who,had
R3533 T7216 T7213 relcl had,disease
R3534 T7217 T7218 amod multiple,tender
R3535 T7218 T7216 dobj tender,had
R3536 T7219 T7218 cc and/or,tender
R3537 T7220 T7221 amod swollen,joints
R3538 T7221 T7218 conj joints,tender
R3539 T7222 T7221 cc and,joints
R3540 T7223 T7224 amod elevated,serum
R3541 T7224 T7221 conj serum,joints
R3542 T7225 T7226 compound CRP,level
R3543 T7226 T7216 npadvmod level,had
R3544 T7227 T7228 punct (,≥
R3545 T7228 T7230 nmod ≥,mg/l
R3546 T7229 T7230 nummod 10,mg/l
R3547 T7230 T7226 appos mg/l,level
R3548 T7231 T7226 punct ),level
R3549 T7232 T7216 punct ;,had
R3550 T7233 T7210 cc and,patients
R3551 T7234 T7235 nummod eight,patients
R3552 T7235 T7210 conj patients,patients
R3553 T7236 T7235 prep with,patients
R3554 T7237 T7238 amod inactive,disease
R3555 T7238 T7236 pobj disease,with
R3556 T7239 T7238 punct ",",disease
R3557 T7240 T7241 nsubj who,satisfied
R3558 T7241 T7210 relcl satisfied,patients
R3559 T7242 T7244 det the,College
R3560 T7243 T7244 compound American,College
R3561 T7244 T7241 dobj College,satisfied
R3562 T7245 T7244 prep of,College
R3563 T7246 T7248 amod Rheumatology,criteria
R3564 T7247 T7248 amod preliminary,criteria
R3565 T7248 T7245 pobj criteria,of
R3566 T7249 T7248 prep for,criteria
R3567 T7250 T7251 amod clinical,remission
R3568 T7251 T7249 pobj remission,for
R3569 T7252 T7254 nmod [,]
R3570 T7253 T7254 nummod 26,]
R3571 T7254 T7244 appos ],College
R3572 T7255 T7204 punct .,divided
R3573 T7256 T7258 nummod Sixteen,volunteers
R3574 T7257 T7258 amod healthy,volunteers
R3575 T7258 T7273 nsubj volunteers,served
R3576 T7259 T7258 punct (,volunteers
R3577 T7260 T7261 nummod 11,women
R3578 T7261 T7258 appos women,volunteers
R3579 T7262 T7261 cc and,women
R3580 T7263 T7264 nummod five,men
R3581 T7264 T7261 conj men,women
R3582 T7265 T7258 punct ;,volunteers
R3583 T7266 T7258 appos age,volunteers
R3584 T7267 T7266 punct ",",age
R3585 T7268 T7269 nummod 45.8,±
R3586 T7269 T7266 appos ±,age
R3590 T7273 T7273 ROOT served,served
R3591 T7274 T7273 prep as,served
R3592 T7275 T7274 pobj controls,as
R3593 T7276 T7273 punct .,served
R3594 T7277 T7278 compound ST,samples
R3595 T7278 T7280 nsubjpass samples,obtained
R3596 T7279 T7280 auxpass were,obtained
R3597 T7280 T7280 ROOT obtained,obtained
R3598 T7281 T7280 prep from,obtained
R3599 T7282 T7284 nummod three,patients
R3600 T7283 T7284 compound RA,patients
R3601 T7284 T7281 pobj patients,from
R3602 T7285 T7284 acl undergoing,patients
R3603 T7286 T7288 amod total,replacement
R3604 T7287 T7288 compound knee,replacement
R3605 T7288 T7285 dobj replacement,undergoing
R3606 T7289 T7280 punct .,obtained
R3607 T7290 T7291 det All,patients
R3608 T7291 T7292 nsubj patients,gave
R3609 T7292 T7292 ROOT gave,gave
R3610 T7293 T7294 amod informed,consent
R3611 T7294 T7292 dobj consent,gave
R3612 T7295 T7292 punct .,gave
R3587 T7270 T7271 nummod 11.2,years
R3588 T7271 T7269 appos years,±
R3589 T7272 T7258 punct ),volunteers

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T6872 752-760 Positive_regulation denotes elevated
T6871 761-770 Protein denotes serum CRP
T6870 579-582 Protein denotes IgM
T6869 545-548 Protein denotes CRP
T6868 519-543 Protein denotes serum C-reactive protein
R3192 T6871 T6872 themeOf serum CRP,elevated